January 19, Scientists have discovered a molecule that can selectively kill cells of a hard-to-treat subtype of breast cancer, which could lead to a new therapy. Triple negative breast cancer is a subtype of breast cancer which is mainly treated with chemotherapy. The researchers tested different molecules to see if they could selectively kill the cells of this type of breast cancer while sparing normal cells. They found that a specific molecule, BAS-2, was able to do this.
The Who, What, Where, When and Sometimes, Why.
After Chemotherapy for Breast Cancer | Memorial Sloan Kettering Cancer Center
Chemotherapy chemo uses anti-cancer drugs that may be given intravenously injected into your vein or by mouth. The drugs travel through the bloodstream to reach cancer cells in most parts of the body. Occasionally, chemo may be given directly into the spinal fluid which surrounds the brain and spinal cord. Not all women with breast cancer will need chemo, but there are several situations in which chemo may be recommended:. For certain types of breast cancer, if there are tumor cells still found at the time of surgery also called residual disease , you may be offered more chemotherapy after surgery to reduce the chances of the cancer coming back recurrence. Sometimes it is not clear if chemotherapy will be helpful.
Chemotherapy for Breast Cancer
About 3, breast cancer cases are detected in Ireland each year, of which about 70 per cent are at the early stage. Photograph: iStock. Your Web Browser may be out of date. If you are using Internet Explorer 9, 10 or 11 our Audio player will not work properly.
Statins, common cholesterol-lowering medications, may protect women's hearts from damage caused during chemotherapy for early-stage breast cancer, according to new research published today in the Journal of the American Heart Association , an open access journal of the American Heart Association. Previous small studies have suggested that women taking statins may have less heart muscle damage from these types of chemotherapy. The exact mechanisms of how statins protect against the cardiac cell damage remains unknown. It is believed that statins have antioxidative and anti-inflammatory actions. For the current study, researchers used several administrative health databases in Ontario, Canada, to review the occurrence of heart failure in women ages 66 and older who received anthracyclines or trastuzumab for newly diagnosed early-stage breast cancer between and